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For over 300 years, scientists have understood that stimulation, in the form of an electrical impulse, is required for
normal muscle function. More recently, the role of specific parameters of the electrical impulse (i.e., the pulse
amplitude, pulse width, andwork-to-rest ratio) has become better appreciated. However, most existing bioreactor
systems do not permit sufficient control over these parameters. Therefore, the aim of the current study was to
engineer an inexpensive muscle electrical stimulation bioreactor to apply physiologically relevant electrical
stimulation patterns to tissue-engineered muscles andmonolayers in culture. A low-poweredmicrocontroller and
a DC–DC converter were used to power a pulse circuit that converted a 4.5V input to outputs of up to 50V, with
pulse widths from 0.05 to 4ms, and frequencies up to 100Hz (with certain operational limitations). When two-
dimensional cultureswere stimulated at high frequencies (100Hz), this resulted in an increase in the rate of protein
synthesis (at 12 h, control [CTL]¼ 5.0 0.16; 10Hz¼ 5.0 0.07; and 100Hz¼ 5.5 0.13 fmol=min=mg) showing
that this was an anabolic signal.When three-dimensional engineeredmuscles were stimulated at 0.1ms and one or
two times rheobase, stimulation improved force production (CTL¼ 0.07 0.009; 1.25V=mm¼ 0.10 0.011;
2.5 V=mm¼ 0.14146 0.012; and 5V=mm¼ 0.03756 0.008 kN=mm2) and excitability (CTL¼ 0.53 0.022;
1.25V=mm¼ 0.44 0.025; 2.5V=mm¼ 0.41 0.012; and 5V=mm¼ 0.60 0.021V=mm), suggesting enhanced
maturation. Together, these data show that the physiology and function of muscles can be improved in vitro using
a bioreactor that allows the control of pulse amplitude, pulse width, pulse frequency, and work-to-rest ratio.
Introduction
One of the most important cues for functional muscledevelopment is the electrical impulse the tissue receives
from the central nervous system via the motor neurons.1
When muscles are denervated in utero, the aneural myotubes
fail to develop fully.1–4 Instead, the muscles are developmen-
tally arrested at the primary myotube stage and do not con-
tinue to develop into adult phenotype myofibers. Similarly,
all attempts to date to engineer muscle have resulted in a
developmental block at the level of primary myotubes.5 Dur-
ing development, the transition from primary myotubes to
secondary myotubes is dependant on electrical activity. In
the absence of electrical activity, secondary myotubes and
adult muscle fibers fail to form.4 Therefore, we hypothesized
that if the electrical stimulation pattern can be reproduced
in vitro, this may promote the transition toward adult myo-
fibers within engineered muscles.
In denervated muscle in vivo and for in vitro tissue engi-
neering experiments, the absence of the nerve requires that
stimulation be provided by systems that emulate neural
function using low-intensity electrical pulses. The use of elec-
trical stimulation of muscle tissue has a long history6; how-
ever, control of important stimulation parameters such as
pulse widths, frequency, and voltage amplitude has been
poorly understood.7 It is only within the last four decades
that the effect of different stimulation patterns on muscle
function has been fully appreciated.8 One of the key aspects
of muscle physiology that is determined by the parameters of
stimulation is fiber type. In an elegant experiment, Salmons
and Vrbova9 demonstrated that the frequency of electrical
input was a key determinant of whether a muscle was fast or
slow. The importance of regulating the electrical impulse
together with advanced electronic component technologies
means that new stimulation systems (bioreactors) can be
developed that enable more complex and physiologically
relevant stimulation patterns to be applied. Many of these
systems are developed in-house by individual laboratories to
address specific experimental requirements.10–12 As a result,
these stimulator systems tend not to offer much flexibility in
the range of parameters that are controlled by the inves-
tigators. Other systems such as Grass stimulators13,14 and
the Ionoptix C-Pace15 have been developed to provide
some parametric versatility.16 However, these commercial
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products are designed for whole animal physiology (Grass)
or standard two-dimensional (2D) tissue culture (C-Pace)
and are of limited use for three-dimensional (3D) tissue en-
gineering. Further, there is a cost barrier associated with
these products that makes these units unattainable for many
labs, especially those looking to do large-scale experimen-
tal deployments that would require correspondingly large
numbers of stimulator systems. If new inexpensive, high-
throughput options were available, rapid advances in un-
derstanding muscle development, disease, growth, and
metabolism would be possible.
The aim of the current work was to develop a bioreactor
system that could be used to stimulate muscle in either two
or three dimensions in vitro. These bioreactors were designed
around a reprogrammable custom electrical stimulation cir-
cuit that offers the flexibility of the commercial systems but
with much lower cost of ownership. The system uses existing
tissue culture plastic in conjunction with rapid prototyped
enclosures to allow a single circuit to stimulate six samples
simultaneously. Further, we show that the physiological stim-
ulation parameters can directly affect the response to stim-




The stimulator circuit is designed to provide programmed
electrical pulses at amplitudes of up to 50V and pulse widths
down to 50ms. Figure 1 shows the schematic for the circuit
highlighting the three constituent parts, namely, the micro-
controller, a DC–DC converter, and the pulse circuit.
The microcontroller used in this circuit was a Microchip
18LF4550, which is a low-power 16-bit chip with 35 IO pins,
universal serial bus (USB) communications, and in-circuit
serial programming (ICSP) programming capabilities. The
LF version of the chip was chosen to allow the stimulator
circuits to be used in a low-power mode such that they could
run off 3-AA batteries instead of using power supplies. This
feature may be of particular use in applications where in vivo
stimulation is required. As shown in Figure 1, Pins B0 to B3
are connected as control output pins for the pulse circuit, and
Pin B4 is used as a control pin for the DC–DC converter chip.
Pins B5–B7 and master clear (MCLR) are connected to an
RJ45 connector to allow for ICSP programming. To allow for
future development and integration with sensors, Pins A0,
A1, A4, and A5 are wired to a 10-pin connector along with
FIG. 1. Circuit diagram of the stimulation bioreactor. Schematic for the circuit highlighting (A) the microcontroller, (B) the
DC–DC converter, and (C) the pulse circuit.
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the USB data pins, þ5V, and ground. Pin C7 is connected
through a 510 O resistor to a red LED to give a visual indi-
cation when the circuit is in operation.
The DC–DC converter circuit is based around the MAX668
step-up PWM controller (Maxim), which has an input volt-
age range of 1.8–28V and provides up to 20W output. The
output voltage is set by the ratio of R2 and R3 according to






where Vref is a reference voltage of 1.25V supplied by pin 5
of the MAX668.
In the stimulator circuits, R2 is a potentiometer with a
maximum resistance of 1MO, R3 is a fixed resistor of 23.2 kO,
giving a maximum Vout of 50V. The voltage is generated
through the high-frequency (500 kHz) switching of an in-
ductor, and the design guidelines indicate the optimum
value of this component can be calculated using the follow-
ing formula (equation 2):
Lideal¼ Vout
(4· Iout · fosc)
:
As the charging currents for the stimulation capacitors
govern Iout, the maximum value is likely to be when both
capacitors require to be charged from full discharge. In this
case, the charging currents are limited by the series 1 kO
resistors in each capacitor circuit, leading to a maximum
value of 110mA for the output current. Feeding this back
into Equation 2, and using our chosen switching frequency of
500 kHz, this gives us an ideal inductance of 250 mH. As in
previous studies, due to the relatively low duty cycle of the
stimulations, lower inductances could be used where nec-
essary; although values down to 22 mH were tried and found
to work adequately, the optimum value chosen was 100 mH.
An input capacitor of 220 mF was used to reduce the cur-
rent burden for the power supply, and a capacitor of similar
value, but rated at greater than Vout, was used to reduce
the voltage ripple and support the output during periods of
high demand. All the components in the DC–DC converter
circuit were chosen to minimize circuit losses that meant low
DC resistance for the inductor and low equivalent series
resistance for the capacitors. This criterion meant that the
ZVN3306 field effect transistor was selected due to its low
switching losses at the 500 kHz operating frequency. The
high switching frequency also meant that a Schottky rectifier
diode MA27111 (Panasonic) was used due to its high-speed
response.
Pulse circuit
The pulse circuit used in the stimulators was based on a
design used in previous in vivo systems.17,18 Briefly, the cir-
cuit functions by charging capacitors to the required stimu-
lation voltage. These are then discharged through muscle
tissue, cell monolayers, or 3D muscle constructs via parallel
metal electrodes using a growth medium as a conductive
path. Using this method allows the quantification of the
stimulation pulse using the rheobase (R50) and chronaxie
(C50) definitions established elsewhere.19 The capacitors are
discharged through an arrangement of IRF7341 and IRF7343
FET transistors, which operate similar to an H-bridge motor
drive system. The gates of the FETs are connected to the
microcontroller such that it allows one electrode to be swit-
ched to ground immediately before connecting the other to
the pulse capacitor for discharge. On completion of the
stimulation, the FETs are switched off returning the elec-
trodes to a high impedance state to decrease medium elec-
trolysis. The stimulation pulses are designed to be bipolar to
minimize electrolysis of the medium and oxidation of the
electrodes, and these can either be alternating bipolar or
paired bipolar. One of the modifications of this derivation to
the original circuit is the use of individual pulse capacitors
for each electrode. This modification was introduced as it
was found that in the case of paired bipolar pulses, the
second pulse was of lower amplitude than the first in high-
frequency stimulation patterns. A second modification to the
original was the introduction of a voltage divider circuit to
the gates of the P-channel transistor in the IRF7343 FETs.
This was due to the original configuration allowing the Vgs
ratings for these transistors to be fatally exceeded at the
higher stimulation amplitudes.
High-frequency limitations
The stimulator circuits are designed optimally for use at
lower frequencies (up to 20Hz); however, they can also be
operated up to 100Hz with some limitations. The main lim-
iting factor in high-frequency operation is the need to re-
charge the capacitors in between stimulation pulses. To
achieve this, we have modified some boards to include a
parallel charging resistor of 100 O. This modification oper-
ates well at output voltages of up to 30V for six wells and up
to 40V if three or fewer wells are used. Thus, the circuits can
be used unaided in the high-frequency stimulation of 3D
constructs, as the maximum amplitude used in these exper-
iments is 20V. For the 2D stimulation work, to mitigate some
of the limitations at high frequency and voltage, the circuits
can be used in conjunction with a standard amplifier such as
the Crown K2 (Crown Audio, Elkhart, IN)
Bioreactor assemblies
Along with the stimulator circuits, the tissue culture plates
are designed around standard tissue culture plastic. For 3D
applications, the assembly comprises a baseplate that holds
up to six 35mm plates (Fig. 2A), whereas for 2D applications
standard six-well plates are used (Fig. 2B). In both cases, four
stimulating bioreactors can easily fit onto a single shelf in a
standard cell culture incubator. The lid assembly is comprised
of six sets of parallel electrodes embedded within a single lid.
Figure 2 shows the prototype design that was used in the
current study, whereas new rapid-prototyped lids are cur-
rently in use. The baseplates for the 3D assembly were de-
signed using the Solidworks CAD package. Each baseplate
has six wells in a 32 pattern, similar to standard six-well cell
culture plates, and each well has a concentric cut-out in the
bottom to allow imaging of the constructs during stimulation
via an inverted microscope. The well centers and overall
baseplate dimensions were chosen to mate with the electrode
lids. The final designs were converted into STL file format and
manufactured in polycarbonate using a StrataSys Titan FDM
rapid prototyping system (StrataSys, Eden Prairie, MN).
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The lid assemblies comprised the plastic lid into which
parallel U-shaped stainless steel electrodes were embedded
with 10mm (for 3D applications) or 20mm (for 2D applica-
tions) spacing. Crimp connectors on the end of the electrodes
allowed for the soldering of wires to connect them to the
stimulator circuit.
Circuit programming
Stimulation protocols were written in the C program-
ming language and compiled using CCS PIC C compiler. The
compiled hex code was then used to program the micro-
controllers using Microchip MPLAB software and ICD-2 USB
programmer. Within the program are two functions, STIM1
and STIM2, that send pins B0–B3 high or low in the correct
sequence to activate the FETs and provide a pulse at one or
other of the electrodes. Functions are also used to turn all
the FETs off in between pulse sequences, thus ensuring the
outputs are in the high-impedance state. This also provides a
delay routine that can be looped, allowing long delay periods
without the watchdog timer tripping. The main function ini-
tially switches on pin B4 to activate the DC–DC converter. This
is followed by a delay period of 5 s to fully charge the capaci-
tors before running the pulse sequences. Finally, the pulse se-
quences are activated with first STIM1 and then STIM2
functions being called, held for the required pulse width, and
then switched off. The variable parameters in the program
include the pulse width, pulse frequency, and the duty cycle.
Thus, it is possible to produce more complex stimulation pat-
terns with more physiologically relevant work to rest ratios.
Two-dimensional cell culture
C2C12 myoblasts were cultured in 35mm plates (Dul-
becco’s modified Eagle’s medium [DMEM], 10% fetal bovine
serum, 1% Pen=strep; Invitrogen, Paisley, United Kingdom)
until 90% confluent when they were differentiated (DMEM,
2%HS, 1% Pen=strep; Invitrogen). All experiments took place
after 5 days of differentiation on fully formed myotubes.
Immediately after stimulation, cells were collected in lysis
buffer (50mM Tris pH 7.5; 250mM Sucrose; 1mM ethyle-
nediaminetetraacetic acid; 1mM ethylene glycol tetraacetic
acid [EGTA]; 1% Triton X-100; 1mM NaVO4; 50mM NaF;
0.10% dithiothreitol [DTT]; 0.50% programmable interface
controller [PIC]), shaken at 48C for 20min (8,000RPM), and
centrifuged for 5min at 12,000RPM, and the supernatant
was removed for protein determination. Protein concentra-
tion was determined using the DC protein assay (Bio Rad,
Hertfordshire, United Kingdom) and equal aliquots of pro-
tein were boiled in Laemmli sample buffer.
Protein synthesis
Protein synthesis was assessed as the incorporation of [35S]
labeled methionine=cysteine (EasyTagTM Express Protein
Labelling Mix, NEN Life Science Products). After stimula-
tion, cells were maintained in serum-free DMEM. One hour
before cell labeling, full DMEM was replaced with DMEM
lacking methionine and cysteine. After this preincubation
period, 3.66 mCi of a [35S] methionine=cysteine mixture was
added to each well and the cells were returned to the incu-
bator for 2 h. Cells were lysed 3, 6, 12, and 24 h after stimu-
lation in a buffer containing 20mM Tris pH 7.4, 150mM
NaCl, 1mM Igepal C630 (NP-40), 10% glycerol, 50mM b-
glycerophosphate, 50mMNaF, and a protease inhibitor cock-
tail. Cell lysates were centrifuged for 2min at 13,000RPM
and 15mL of the supernatant was spotted on a Whatman
paper in duplicate. Whatman papers were washed three
times in 5% trichloroacetic acid containing cold methionine
and cysteine, rinsed once in ethanol, and dried at 378C. Four
milliliters of scintillating liquid (Ultimagold; Perkin Elmer,
Monza [Milano], Italy) was then added to the papers and
[35S] incorporation was counted in a scintillation counter
(Beckman, High Wycombe, United Kingdom) for 2min.
Three-dimensional cell culture
The 3D culture method was recently reported elsewhere.20
Briefly, the muscle constructs were engineered between two
6-mm-long silk sutures set 12mm apart on Sylgard poly
dimethyl siloxane (PDMS)-coated dishes. Five hundred mi-
croliters of the growth medium containing 10U=mL throm-
bin, 0.2 mg=mL genipin, and 50 ng=mL insulin-like growth
factor-1 was added to the plate and agitated until it covered
the entire surface; 200 mL of 200mg=mL fibrinogen was ad-
ded dropwise and the gels were left to polymerize for 1 h
before addition of 100,000 cells. Cells were given fresh
growth media every other day until the cells were *90%
confluent, at which point the constructs were switched to
FIG. 2. Two-dimensional (2D) and three-dimensional (3D)
stimulation bioreactor prototypes. Images of the prototype
(A) 2D muscle-stimulating bioreactor and (B) 3D muscle-
stimulating bioreactor.
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DMEM supplemented with 10% horse serum and 1% peni-
cillin=streptomycin for 2 days. After the second day in dif-
ferentiation media, the constructs were moved to DMEM
with 7% fetal bovine serum and 1% penicillin=streptomycin
for the remainder of the experiment.
Construct testing
Functional testing of the C2C12 constructs was performed
as described previously.21 Briefly, one of the anchors was
freed from the Sylgard substrate and attached to a custom-
made force transducer via one the minutien pins. R50 and
C50 were determined as described previously.21 R50 was
calculated as the electric field strength (V=mm) required to
elicit 50% peak twitch force at a 4ms pulse width. Chronaxie
was calculated as the pulse width required to elicit 50%
(peak twitch force) at twice R50. Maximum tetanic force was
calculated at twice R50 at 4ms using a 1 s train at 150Hz for
each individual construct. Cross-sectional area was calcu-
lated from the measured width of each construct (at its
narrowest point), assuming a rectangular cross section and a
depth of 500 mM. Specific force was calculated as kilo-
newtons per square meter: the force generated by the con-
struct (kN) divided by its cross-sectional area (m2).
Muscle cell stimulation
In 2D, the cells were stimulated at either 10Hz (40.3ms
pulses delivered in 400ms trains with 3.6 s recovery) or
100Hz (400.3ms pulses delivered in 400ms trains with
3.6 s recovery). The 10Hz protocol lasted 3 h, whereas the
100Hz protocol lasted 30min to model previous work per-
formed using in tact muscle.22 In 3D, the constructs were
stimulated with 40.1ms pulses delivered in a 400ms train
followed by 3.6 s recovery. This stimulation program was
maintained throughout the entire 7 days of the study.
Statistical analysis
ANOVA (BrightStat.com) analysis followed by a Tukey
HSD post-hoc test was used to determine differences be-
tween groups. Values are displayed as mean standard
error of the mean, with statistical significance set at 0.05
Results
Two-dimensional electrical stimulation at different
frequencies results in different cellular responses
To determine the effect of electrical stimulation on the cel-
lular response of C2C12 muscle cells, 2D myotubes were
stimulated with 0.3ms pulses at low (10Hz) and high
(100Hz) frequencies. The pulses were delivered in 400ms
trains with 3.6 s recovery. The length of the stimulation pro-
tocol was adopted from previous research in vivo that showed
that 3 h at 10Hz had no effect on muscle protein synthesis,
whereas 30min at 100Hz increased protein synthesis.22 Low-
frequency electrical stimulation had no effect on the rate of
muscle protein synthesis (control [CTL] 3 h¼ 4.66 0.15;
10Hz 3h¼ 4.85 0.13; CTL 12 h¼ 4.98 0.16 10Hz 12h¼
5.0 0.07; CTL 24 h¼ 4.36 0.05 10Hz 24h¼ 4.24
0.09 fmol=min=mg) at any time point after stimulation (Fig. 3).
In contrast, the higher frequency stimulation group showed
a statistically significant increase in protein synthesis
(3 h¼ 5.18 0.10; 12 h¼ 5.50 0.13; 24 h¼ 4.51 0.09 fmol=
min=mg).
Excitability of C2C12 muscle constructs
Since electrical damage is common when muscle is stim-
ulated in vitro and C2C12 have been reported to have poor
excitability, the C50 and R50 were determined for the fibrin-
based C2C12 constructs. The excitability of control C2C12
muscle constructs was higher than has previously been re-
ported for C2C12 constructs (R50¼ 0.35 0.025V=mm;
C50¼ 474 19.8ms) 2 weeks after differentiation.21 At 5 weeks
after differentiation, the constructs were less excitable
(R50¼ 0.62 0.018V=mm;C50¼ 896 45.5 ms) anddisplayed
a qualitative decrease in spontaneous contractile activity.
Three-dimensional stimulation increases
muscle force production
To determine the effect of chronic electrical stimulation
on the function of engineered C2C12 muscle constructs, R50
was first determined in 2-week-old constructs. The con-
structs were then stimulated at one, two, or four times R50
FIG. 3. Effect of stimulation at dif-
ferent frequencies on protein synthe-
sis. C2C12 myotubes were stimulated
with low-frequency (10Hz) or high-
frequency (100Hz) electrical pulses,
and the rate of protein synthesis 3, 6,
12, and 24 h later was determined.
The pulses were delivered in 400ms
trains with 3.6 s recovery. The 10Hz
stimulation lasted for 3 h, whereas the
100Hz stimulation lasted for 30min.
*Significantly higher than control
( p< 0.05).
MUSCLE STIMULATION BIOREACTOR 715
while maintaining the pulse width at 0.1ms. The groups
were stimulated with the 10Hz protocol described above,
where the muscles received one tetanus consisting of 4 pulses
delivered in 400ms with 3.6 s recovery.
Stimulation at 1.25V=mm tended to increase force pro-
duction and significantly decreased R50 (Fig. 4). At 2.5V=mm
both force and R50 were improved, whereas both force and
R50 were negatively affected by stimulation at 5V=mm.
Chronaxie was unchanged in any of the groups These data
indicate that, in vitro, high-voltage stimulation negatively
affects 3D engineered muscle performance.
Discussion
We have developed a muscle electrical stimulation biore-
actor that (1) can be used for either 2D or 3D muscle cultures,
(2) is powered by batteries or inexpensive 5V power sources,
(3) is easily reprogrammed, and (4) allows investigator con-
trol over the voltage amplitude, stimulation frequency, pulse
width, and work-to-rest ratio. Further, we have shown that
important physiological differences result when changing
not only the frequency, but also the amplitude of stimulation.
Stimulating the 2D cultures at high frequencies resulted in an
anabolic signal (increased protein synthesis), whereas stim-
ulating 3D muscle constructs with high voltages decreased
force generation and excitability.
Although some commercial muscle stimulators are on the
market, these units tend to be very expensive as they are
engineered for a variety of functions, in vivo and in vitro,
nerve and muscle, and so on, and as a result, many of the
specific requirements for muscle tissue engineering applica-
tions are under represented. Further, although some of these
systems effectively stimulate cells in 2D, none are currently
designed for stimulating 3D muscle constructs. The stimu-
lators reported here are highly flexible in their design
parameters. Initially, these have been designed to use a
six-well-plate format since this is routinely used within lab-
oratories, allows moderate throughput, and is ideal for
discovery-based bioreactors. As the ideal parameters for
stimulation of the muscle cells in culture are determined, the
system can be scaled as necessary for either clinical appli-
cations or delivery-based systems (that would increase the
throughput of the system).
This is the first report of the C50 and R50 of fibrin-based
engineered muscles. Previous reports on cocultures of C2C12
muscle cells and 10T1=2 fibroblasts21 have indicated that the
C2C12 cells had the excitability of chronically denervated
skeletal muscle (R50 *1.93V=mm, C50 *416 ms). Here we
show that when the C2C12 constructs are formed using
fibrin gel casting, the C50 is initially very similar (474
19.8 ms), whereas the R50 value (0.35 0.025V=mm) is ap-
proximately fivefold lower. At 5 weeks in culture, the fibrin
gel cast C2C12 constructs still have a lower R50, but C50 is
greater (896 45.5 ms) than the C2C12 and 10T1=2 cocultures.
This suggests that higher amplitude pulses are required to
excite skeletal muscle cells when surrounded by a dense
extracellular matrix (the C2C12-10T1=2 cocultures), but
smaller stimulus durations may be propagated efficiently.
This might be a direct result of the electrical connections
formed by fibroblasts within the culture23; once these cells
within their dense extracellular matrix have been depolar-
ized, they are able to readily propagate the electrical signal.
However, since we have shown that greater pulse ampli-
tudes result in a decrease in excitability over time, this sug-
gests that the fibrin cast constructs may be better suited to
long-term stimulation.
One of our initial hypotheses was that electrical stimula-
tion would overcome the developmental block within the
engineered muscles. Stimulation using 0.1ms pulse widths
and voltages of 1–2 times R50 improved force production
and excitability, suggesting that using physiological models
of electrical stimulation results in a more mature muscle.
Even though we have not quantified the developmental state
of the contractile machinery, excitability is an effective mar-
ker of the developmental state of muscle24 and therefore can
be used as a nondestructive biomarker of development.7
In vivo, skeletal muscle contracts when an action potential is
propagated along the surface of the muscle cell membrane
causing depolarization of the t-tubular membrane and con-
sequent calcium release from the sarcoplasmic reticulum.
However, whether stimulation via parallel electrodes mimics
this physiological depolarization has recently been ques-
tioned.25 Unlike neural stimulation, Cairns et al.25 demon-
strated that using parallel electrodes and pulse widths longer
than 0.25ms results in direct calcium release from the sar-
coplasmic reticulum and not surface membrane propagation
using the t-tuble system. We therefore used 0.1ms pulse
widths to promote surface propagation of action potentials
FIG. 4. Effect of 1-week stimulation with different pulse
amplitudes and a pulse width of 0.1ms on engineered
muscle function. (A) Force and (B) rheobase (R50) (R50 de-
termined with 4ms pulse width) were determined in groups
stimulated for 1 week at 1.25, 2.5, 5V=mm, which corre-
sponded to 1, 2, and 4 R50 at 0.1ms. *Significantly different
from control ( p< 0.05). Note that decreased R50 is indicative
of a more excitable muscle. Graph shows representative data
(n¼ 6) of one of the two trails.
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in case this provides important developmental cues. How-
ever, it should be noted that we see the same increase in force
and decrease in R50 using longer pulse widths (A. Khoda-
bukus, unpublished observations).
The decrease in force and increase in R50 at 5V=mm
indicates that too much voltage has negative effects on en-
gineered muscle performance. The most likely cause of this
negative effect is electrochemical damage due to the high
voltage.26 Classically, electrochemical tissue damage is pre-
vented by using stimulation protocols with the least energy,
pure bipolar pulses, and high-impedance output when not
stimulating.26 The current data add to this previous work
by suggesting that while the stimulus pulse energy is im-
portant, the voltage used plays a greater role in electro-
chemical damage than pulse width.
Electrical stimulation of muscle cells in 2D is becoming
increasingly popular for studying the molecular effects of
exercise on mitochondrial biogenesis, and insulin sensitivity.
Our preliminary work showed that high-voltage stimulation
(2–2.5V=mm) or frequencies over 3Hz would rapidly kill the
2D C2C12 muscle cells. Using the 3D C2C12 constructs to
determine the R50 values allowed us to decrease the voltage
used to 1V=mm, and cell survival has not been a problem for
up to 3 days when the cells pull off the plates (A. Philp,
unpublished observations). Further, using the 3D C2C12
muscle constructs we noted that a fused tetanus occurs with
stimulation frequencies in excess of 3Hz (A. Khodabukus,
unpublished observations). Accordingly, lower frequencies
or different protocols were required. Therefore, when de-
signing the 2D stimulation protocols a pulse train approach
was developed. This means that for C2C12 muscle cells any
frequency of stimulation over 1Hz should be provided as a
train of pulses followed by a rest period. Even when pulses
are provided in this manner, varying the frequency of
stimulation results in different physiological responses from
the cells. At higher frequencies, there was a transient increase
in the rate of protein synthesis. This is similar to what occurs
after resistance exercise that results in muscle growth.27 This
difference has also been observed in situ. Using the same
patterns of electrical stimulation, Atherton et al.22 have
shown that high-frequency stimulation results in an increase
in whole muscle protein synthesis, whereas 10Hz stimula-
tion for 3 h does not. The ability to reproduce what has been
observed in whole muscle and also maintain the muscle
culture for at least 3 days makes this form of electrical stim-
ulation a good model for in vivo muscle physiology.
Nedachi et al.28 have previously performed a 24-hour, 1Hz
continuous stimulation protocol (IonOptix C-Dish) on C2C12
cells in culture using a 2ms pulse width and 0.67V=mm.
Although they did not determine the rate of protein syn-
thesis, they did see an increase 50adenosine monophosphate-
dependent protein kinase (AMP kinase) activity. Since AMP
kinase activity is increased by metabolic stress and can inhibit
protein synthesis, it is possible that the low-frequency, long-
duration stimulation that we performed resulted in greater
AMP kinase activity and therefore less protein synthesis than
the short-duration, high-frequency stimulation. Consistent
with this hypothesis, Atherton et al.22 have previously
demonstrated that isometric contractions in isolated rat
muscles with continuous low-frequency stimulation in-
creased AMP kinase activity but did not increase protein
synthesis, whereas 30min of high-frequency stimulation did
not alter AMP kinase phosphorylation but did increase
protein synthesis. Interestingly, Nedachi et al. also reported
an increase in slow myosin heavy chain and a reorganization
of the sarcomeres that might translate into better force pro-
duction.28 This cellular reorganization might play a role in
the increase in force production that we observe in 3D.
In conclusion, we have developed an inexpensive muscle
electrical stimulation bioreactor for either 2D or 3D muscle
cultures. This bioreactor allows researchers to apply physi-
ologically relevant electrical stimulation patterns to tissue-
engineered muscles and monolayers in culture. Further, we
have shown that the voltage amplitude is a key determinant
of the response of engineered muscle when stimulated in vitro
and that stimulation frequency and duration are important
in the anabolic response in 2D muscle cell culture. We believe
that this bioreactor system will have wide application for
both basic research, where it could be used to deduce how
stimulation drives a muscle to be fast or slow, and clinical
research, where it may provide insight into metabolic dis-
eases such as diabetes.
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